Our Medical Experts
BLK-Max Hospital is home to 350+ eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
Find a DoctorEmergency:
Helpline:
Acute Myeloid Leukemia Acute myeloid leukaemia (AML) is the cancer of the blood and bone marrow leading to the formation of abnormal blood cells. It is the most common type of leukaemia in the adult population.
Blood and bone marrow
Acute myeloid leukaemia is considered to be caused by the following factors:
Change in genes or mutations can be acquired and caused by various factors such as exposure to radiation, chemotherapy, etc.
Family history is also considered to be responsible for the faulty gene transfer to generations and causing leukaemia.
Acute myelogenous leukaemia or acute myeloblastic leukaemia
Signs and symptoms of acute myeloid leukaemia include the following:
There is no standard staging system for acute myeloid leukaemia. It is generally differentiated as newly diagnosed, remission, and recurrent.
The clinical presentation of acute myeloid leukaemia might mimic symptoms of other conditions such as acute lymphoblastic leukaemia (ALL), bone marrow failure, aplastic anaemia, anaemia, myelodysplastic syndrome (MDS), B-cell lymphoma, chronic myelogenous leukaemia (CML), acute biphenotypic leukaemia, metastasis to certain tumours, etc. Hence, a differential diagnosis is required to rule out these conditions.
The typical test starts with the diagnosis of the patient's medical history, signs, symptoms, and physical examination, followed by blood counts. A peripheral blood smear is used to check for the blast cells. In addition, flow cytometry is used to identify the presence of tumour markers on the cells. Bone marrow aspiration followed by biopsy can be used to look for signs of cancerous growth in the cells. In addition, molecular testing, Immunophenotyping, cytogenetic analysis, etc., could be used to confirm the diagnosis of acute myeloid leukaemia.
The treatment options for acute myeloid leukaemia depend on the patient's stage, gender, and overall health condition. Various treatment options include:
In chemotherapy, Anti-cancer medications are given to kill the cancerous cells.
In stem cell transplantation, Stem cells are transplanted along with chemotherapy to replenish the blood-forming cells.
In radiotherapy, High-intensity radiation is used to destroy cancerous cells.
In targeted therapy, Specific medications targeting the tumour cells/tissues are administered, sparing the healthy cells.
Risk factors for acute myeloid leukaemia include the following:
A weaker immune system is a common complication of acute myeloid leukaemia, leading to various infections. Other complications could include anaemia, nerve damage, kidney problems, weight loss, fertility problems, unexplained fever, bleeding, etc. Untreated acute myeloid leukaemia can spread to other tissues and organs and lead to death.
Although there is nothing much you can do to prevent the onset of acute myeloid leukaemia, you can follow the below-mentioned preventive tips to reduce the risk of developing it:
Secondary prevention aims to reduce the risk of complications and recurrences. The following measure can be taken:
The prognosis of acute myeloid leukaemia depends on the age, stage of cancer, and response to treatment. Cancer treatment is more effective in the initial stages, and the survival rate is higher. The chances of 5-year survival are 10% in therapy-treated patients.
The progression of acute myeloid leukaemia is relatively rapid, and it can spread to other organs and tissues. If left untreated, it can get lethal in a few weeks to a few months.
Acute myeloid leukaemia is a blood and bone marrow cancer characterised by genetic mutations in the hematopoiesis pathways. The mutations lead to defects in DNA structure, causing an undifferentiated growth of the myeloid precursors in the bone marrow and blood, leading to bone marrow failure and the presentation of acute myeloid leukaemia.
Acute myeloid leukemia (AML) is relatively rare, accounting for a small percentage of all cancer cases. Its incidence varies by age, with higher rates among older adults.
Acute myeloid leukemia (AML) is a serious and potentially life-threatening cancer of the blood and bone marrow. The prognosis varies, but prompt diagnosis and treatment at a specialised centre are crucial for the best possible outcomes.
AML (Acute Myeloid Leukemia) can be cured in many cases, particularly with early diagnosis and appropriate treatment, such as chemotherapy or stem cell transplantation. However, the prognosis depends on various factors, including the subtype of AML and the patient's overall health.
Doctors diagnose AML (Acute Myeloid Leukemia) through a combination of blood tests, bone marrow biopsy, and genetic testing to examine the blood and bone marrow for abnormal cells, genetic mutations, and other markers indicative of the disease.
BLK-Max Hospital is home to 350+ eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
BLK-Max Hospital is home to 350+ eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
Find a Doctor